Cargando…

Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention

Since the start of the coronavirus disease 2019 (COVID‐19) pandemic, new variants of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) have emerged, accelerating the spread of the virus. Omicron was defined by the World Health Organization in November 2021 as the fifth “variant of concern...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ailan, Hong, Bixia, Lou, Fuxing, Wang, Shuqi, Li, Wenye, Shafqat, Amna, An, Xiaoping, Zhao, Yunwei, Song, Lihua, Tong, Yigang, Fan, Huahao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380698/
https://www.ncbi.nlm.nih.gov/pubmed/35992968
http://dx.doi.org/10.1002/mco2.172
_version_ 1784768929827127296
author Xu, Ailan
Hong, Bixia
Lou, Fuxing
Wang, Shuqi
Li, Wenye
Shafqat, Amna
An, Xiaoping
Zhao, Yunwei
Song, Lihua
Tong, Yigang
Fan, Huahao
author_facet Xu, Ailan
Hong, Bixia
Lou, Fuxing
Wang, Shuqi
Li, Wenye
Shafqat, Amna
An, Xiaoping
Zhao, Yunwei
Song, Lihua
Tong, Yigang
Fan, Huahao
author_sort Xu, Ailan
collection PubMed
description Since the start of the coronavirus disease 2019 (COVID‐19) pandemic, new variants of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) have emerged, accelerating the spread of the virus. Omicron was defined by the World Health Organization in November 2021 as the fifth “variant of concern” after Alpha, Beta, Gamma, and Delta. In recent months, Omicron has become the main epidemic strain. Studies have shown that Omicron carries more mutations than Alpha, Beta, Gamma, Delta, and wild‐type, facilitating immune escape and accelerating its transmission. This review focuses on the Omicron variant's origin, transmission, main biological features, subvariants, mutations, immune escape, vaccination, and detection methods. We also discuss the appropriate preventive and therapeutic measures that should be taken to address the new challenges posed by the Omicron variant. This review is valuable to guide the surveillance, prevention, and development of vaccines and other therapies for Omicron variants. It is desirable to develop a more efficient vaccine against the Omicron variant and take more effective measures to constrain the spread of the epidemic and promote public health.
format Online
Article
Text
id pubmed-9380698
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93806982022-08-19 Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention Xu, Ailan Hong, Bixia Lou, Fuxing Wang, Shuqi Li, Wenye Shafqat, Amna An, Xiaoping Zhao, Yunwei Song, Lihua Tong, Yigang Fan, Huahao MedComm (2020) Reviews Since the start of the coronavirus disease 2019 (COVID‐19) pandemic, new variants of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) have emerged, accelerating the spread of the virus. Omicron was defined by the World Health Organization in November 2021 as the fifth “variant of concern” after Alpha, Beta, Gamma, and Delta. In recent months, Omicron has become the main epidemic strain. Studies have shown that Omicron carries more mutations than Alpha, Beta, Gamma, Delta, and wild‐type, facilitating immune escape and accelerating its transmission. This review focuses on the Omicron variant's origin, transmission, main biological features, subvariants, mutations, immune escape, vaccination, and detection methods. We also discuss the appropriate preventive and therapeutic measures that should be taken to address the new challenges posed by the Omicron variant. This review is valuable to guide the surveillance, prevention, and development of vaccines and other therapies for Omicron variants. It is desirable to develop a more efficient vaccine against the Omicron variant and take more effective measures to constrain the spread of the epidemic and promote public health. John Wiley and Sons Inc. 2022-08-16 /pmc/articles/PMC9380698/ /pubmed/35992968 http://dx.doi.org/10.1002/mco2.172 Text en © 2022 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Xu, Ailan
Hong, Bixia
Lou, Fuxing
Wang, Shuqi
Li, Wenye
Shafqat, Amna
An, Xiaoping
Zhao, Yunwei
Song, Lihua
Tong, Yigang
Fan, Huahao
Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
title Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
title_full Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
title_fullStr Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
title_full_unstemmed Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
title_short Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
title_sort sub‐lineages of the sars‐cov‐2 omicron variants: characteristics and prevention
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380698/
https://www.ncbi.nlm.nih.gov/pubmed/35992968
http://dx.doi.org/10.1002/mco2.172
work_keys_str_mv AT xuailan sublineagesofthesarscov2omicronvariantscharacteristicsandprevention
AT hongbixia sublineagesofthesarscov2omicronvariantscharacteristicsandprevention
AT loufuxing sublineagesofthesarscov2omicronvariantscharacteristicsandprevention
AT wangshuqi sublineagesofthesarscov2omicronvariantscharacteristicsandprevention
AT liwenye sublineagesofthesarscov2omicronvariantscharacteristicsandprevention
AT shafqatamna sublineagesofthesarscov2omicronvariantscharacteristicsandprevention
AT anxiaoping sublineagesofthesarscov2omicronvariantscharacteristicsandprevention
AT zhaoyunwei sublineagesofthesarscov2omicronvariantscharacteristicsandprevention
AT songlihua sublineagesofthesarscov2omicronvariantscharacteristicsandprevention
AT tongyigang sublineagesofthesarscov2omicronvariantscharacteristicsandprevention
AT fanhuahao sublineagesofthesarscov2omicronvariantscharacteristicsandprevention